Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Carcinogenesis|March 6, 2004
Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosisKeiji Shimada, Syuichi Matsuyoshi, Mitsutoshi Nakamura, et al.
Molecular Carcinogenesis|November 1, 2002
Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cellsKeiji Shimada, Mitsutoshi Nakamura, Eiwa Ishida, et al.
The Prostate|April 25, 2003
c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cellsKeiji Shimada, Mitsutoshi Nakamura, Eiwa Ishida, et al.
The Prostate|November 17, 2007
HRK inactivation associated with promoter methylation and LOH in prostate cancerTomonori Higuchi, Mitsutoshi Nakamura, Keiji Shimada, et al.
Japanese Journal of Cancer Research : Gann|November 6, 2002
Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cellsKeiji Shimada, Mitsutoshi Nakamura, Eiwa Ishida, et al.
Molecular Carcinogenesis|December 25, 2003
The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cellsKeiji Shimada, Mitsutoshi Nakamura, Eiwa Ishida, et al.
Acta Neuropathologica|September 13, 2005
Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomasMitsutoshi Nakamura, Eiwa Ishida, Keiji Shimada, et al.
Pathology International|June 28, 2003
Distribution and secretory pathways of prostate specific antigen, alpha1-antichymotrypsin and prostate secretory granules in prostate cancersEiwa Ishida, Mitsutoshi Nakamura, Keiji Shimada, et al.
Japanese Journal of Cancer Research : Gann|August 1, 2002
DNA hypermethylation status of multiple genes in prostate adenocarcinomasNoboru Konishi, Mitsutoshi Nakamura, Munehiro Kishi, et al.
Oncology|July 1, 2006
Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomasMitsutoshi Nakamura, Eiwa Ishida, Keiji Shimada, et al.
Pageof 5